| Literature DB >> 25064346 |
Sujeet Kumar1, Mahesh Hegde2, Vidya Gopalakrishnan2, Vinaya Kumar Renuka1, Sureshbabu A Ramareddy1, Erik De Clercq3, Dominique Schols3, Anil Kumar Gudibabande Narasimhamurthy4, Sathees C Raghavan2, Subhas S Karki5.
Abstract
The cytotoxic activity of a new series of 2-(4'-chlorobenzyl)-5,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazoles against different human and murine cancer cell lines is reported. Among the tested compounds, two derivatives namely 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde 4i and 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl thiocyanate 5i emerged as the most potent against all the cell lines. To investigate the mechanism of action, we selected compounds 4i for cell cycle study, analysis of mitochondrial membrane potential and Annexin V-FITC flow cytometric analysis and DNA fragmentation assay. Results showed that 4i induced cytotoxicity by inducing apoptosis without arresting the cell cycle.Entities:
Keywords: Anti-cancer drugs; Apoptosis; Cancer therapeutics; Cell death; Cytotoxicity
Mesh:
Substances:
Year: 2014 PMID: 25064346 DOI: 10.1016/j.ejmech.2014.07.054
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514